DEA schedule
Is aprepitant a controlled substance?
Federal schedule for aprepitant from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Aprepitant is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and aprepitant is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted aprepitant?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 21 prescription listings from 7 labelers, none with a DEA schedule |
| DEA controlled substances list | aprepitant is not on the list |
Aprepitant NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 47426-401 | APONVIE | emulsion | 32 mg/4.4mL | Heron Therapeutics, Inc. | None |
| 47426-201 | CINVANTI | injection, emulsion | 130 mg/18mL | Heron Therapeutics, Inc. | None |
| 0006-0462 | EMEND | capsule | 125 mg/1 | Merck Sharp & Dohme LLC | None |
| 0006-0464 | EMEND | capsule | 40 mg/1 | Merck Sharp & Dohme LLC | None |
| 0006-0461 | EMEND | capsule | 80 mg/1 | Merck Sharp & Dohme LLC | None |
| 0006-3066 | EMEND | powder, for suspension | 125 mg/1 | Merck Sharp & Dohme LLC | None |
| 0781-2323 | Aprepitant | capsule | 125 mg/1 | Sandoz Inc | None |
| 13668-593 | APREPITANT | capsule | 125 mg/1 | Torrent Pharmaceuticals Limited | None |
| 51407-703 | APREPITANT | capsule | 125 mg/1 | Golden State Medical Supply, Inc. | None |
| 68001-668 | Aprepitant | capsule | 125 mg/1 | BluePoint Laboratories | None |
| 68462-585 | Aprepitant | capsule | 125 mg/1 | Glenmark Pharmaceuticals Inc., USA | None |
| 0781-2321 | Aprepitant | capsule | 40 mg/1 | Sandoz Inc | None |
| 13668-591 | APREPITANT | capsule | 40 mg/1 | Torrent Pharmaceuticals Limited | None |
| 51407-701 | APREPITANT | capsule | 40 mg/1 | Golden State Medical Supply, Inc. | None |
| 68001-666 | Aprepitant | capsule | 40 mg/1 | BluePoint Laboratories | None |
| 68462-583 | Aprepitant | capsule | 40 mg/1 | Glenmark Pharmaceuticals Inc., USA | None |
| 0781-2322 | Aprepitant | capsule | 80 mg/1 | Sandoz Inc | None |
| 13668-592 | APREPITANT | capsule | 80 mg/1 | Torrent Pharmaceuticals Limited | None |
| 51407-702 | APREPITANT | capsule | 80 mg/1 | Golden State Medical Supply, Inc. | None |
| 68001-667 | Aprepitant | capsule | 80 mg/1 | BluePoint Laboratories | None |
| 68462-584 | Aprepitant | capsule | 80 mg/1 | Glenmark Pharmaceuticals Inc., USA | None |
Questions
Is aprepitant a controlled substance?
No. Aprepitant is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and aprepitant is not on the DEA controlled substances list.
Is aprepitant a narcotic?
No. Aprepitant is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Substance P/Neurokinin-1 Receptor Antagonist.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Aprepitant
- What is Aprepitant used for?FDA label uses
- Generic for EmendFDA Orange Book
- Generic for AponvieFDA Orange Book
- Generic for CinvantiFDA Orange Book
- Substance P/Neurokinin-1 Receptor Antagonists listFDA drug class
- NDC 0006-0461Aprepitant NDC record
- NDC 0006-0462Aprepitant NDC record
- NDC 0006-0464Aprepitant NDC record